NCT05329389

Brief Summary

The cumulative risk of stone recurrence rate is up to 14% at 1 year, 35% at 5 years, and 52% at 10 years. Low urine volume caused by insufficient fluid consumption is one of the most crucial risk factors for kidney stone formation. According to the guidelines, a copious fluid intake to maintain a urine volume of at least 2.0 to 2.5 L/24 h is recommended for most kidney stone formers. Patients often find it difficult to follow the recommendations in fluid intake, which leads to stone recurrence. Therefore, there is a need to improve patient compliance and adherence to following the instructions on keeping water balance. For this purpose we developed a mixed educational program including two parts. The first is the mobile application called "StoneMD: Kidney Stones". The second is the "School for Patients" with kidney stones, which is responsible for the stone clinic effect.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
135

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

1.3 years

First QC Date

March 29, 2022

Last Update Submit

May 6, 2023

Conditions

Keywords

applicationStoneMDSchools of patients

Outcome Measures

Primary Outcomes (2)

  • Volume of daily urine

    The primary outcome will be measured in the lab in international units of measurement

    12 month after the surgery

  • Concentration of creatinine in daily urine

    The primary outcome will be measured in the lab in international units of measurement

    12 month after the surgery

Secondary Outcomes (1)

  • Likert scale questionnaire scores

    12 month

Study Arms (3)

StoneMD

EXPERIMENTAL

Patients will receive standard recommendations of keeping diuresis at the level of 2.5 l/day and to use the StoneMD application on their smartphones after the surgery. Patients will use the section "Water balance" and follow the instructions during the 12 month after the surgery.

Device: StoneMDBehavioral: Standard recommendation

StoneMD & Schools of Patients

EXPERIMENTAL

Patients will receive standard recommendations of keeping diuresis at the level of 2.5 l/day and and recommendations to use the StoneMD application on their smartphones after the surgery. Patients will use the section "Water balance" and follow the instructions during the 12 month after the surgery. Additionally, patients will visit schools during a following year. Patients receive 4 consultations (one per 3 month).

Device: StoneMDBehavioral: Schools of PatientsBehavioral: Standard recommendation

Recommendations only

ACTIVE COMPARATOR

Only fluid balance recommendations given at the day of discharge. Patients will receive recommendations of keeping diuresis at the level of 2.5 l/day after the surgery

Behavioral: Standard recommendation

Interventions

StoneMDDEVICE

StoneMD - is an app from App Store (for iOS) or Google Play (for Android).

StoneMDStoneMD & Schools of Patients

The "Schools for Patients" with Urolithiasis is an online course for patients with urinary stone disease.

StoneMD & Schools of Patients

Only fluid balance recommendations given at the day of discharge.

Recommendations onlyStoneMDStoneMD & Schools of Patients

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Low risk recurrence group patients;
  • Patients after the first stone surgery;

You may not qualify if:

  • Recurrent cases of stone formation;
  • Patients, who do not have smartphones;
  • Patients, who can't visit "Schools for Patients" with kidney stone disease;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SBPSU

Saint Petersburg, 190005, Russia

RECRUITING

Related Publications (5)

  • Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989 Dec 15;111(12):1006-9. doi: 10.7326/0003-4819-111-12-1006.

    PMID: 2688503BACKGROUND
  • Siener R, Hesse A. Fluid intake and epidemiology of urolithiasis. Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S47-51. doi: 10.1038/sj.ejcn.1601901.

    PMID: 14681713BACKGROUND
  • Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, Turk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.

    PMID: 25454613BACKGROUND
  • Becker B, Gadzhiev N, Popiolek M, Gross AJ, Netsch C. [A mobile app for patients suffering from kidney stones]. Urologe A. 2018 May;57(5):577-582. doi: 10.1007/s00120-018-0652-0. German.

    PMID: 29713752BACKGROUND
  • Gadjiev N.K., Gorelov D.S., Akopyan G.N., Gelig V.A., Ivanov A.O., Petrov S.B., Kryukova N.U., Reva S.A., Ponomareva Yu.A., Al-Shukri A.S., Mischenko A.A., Kogai M.A., Vasiliev V.N., Chernysheva D.Yu., Obidnyak V.M., Makar'in V.A., Pisarev A.V., Zakuckij A.N., Kuzmin I.V., Amdiy R.E., Korneyev I.A., Al-Shukri S.H. "Schools for Patients" with Urolithiasis and Prostatic Diseases. Vestnik Urologii. 2020;8(1):110-120. (In Russ.) https://doi.org/10.21886/2308-6424-2020-8-1-110-120

    BACKGROUND

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Nariman Gadzhiev, PhD

    Deputy Medical Director

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vitalii Gelig, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: In case of presence/absence of inclusion/exclusion criteria and written informed consent will be obtained, patients will be randomized in a 1:1:1 ratio according to the list of randomized blocks using a computer generator. Patients will be randomized at the last available moment in order to minimize bias.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD, Urologist, Deputy Medical Director of Saint-Petersburg State University Clinic

Study Record Dates

First Submitted

March 29, 2022

First Posted

April 15, 2022

Study Start

January 1, 2023

Primary Completion

April 4, 2024

Study Completion

July 1, 2024

Last Updated

May 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations